Dario Campana

This paper introduces a chimeric receptor (CARFcR) that combines CAR-T cell potency with antibody targeting, enabling effective cytotoxicity against both CD19+ and CD19- tumor cells using approved antibodies.

Hypergate optimizes flow-cytometry gating strategies for high yield and purity, outperforming human experts and machine learning models on public datasets.